TP53 and retinoblastoma: Finally, we showed that either B02 + Nav or TPT + Nav dual therapies were also effective in RB1021 cells, that triple therapy further enhanced apoptosis in both RB lines, and that p53 was essential for this effect with all these drug combinations (Fig. 6e).